Skip Main Navigation
Page Content

With over 14 years’ pharmaceutical experience, within both consultancy and pharmaceutical companies, Graham brings expertise in embedding market access drivers into clinical development programme; developing global product launch pricing strategies and producing HTA submissions to address payers’ pricing and reimbursement requirements.

Graham’s industry experience includes GSK, start-up biotech companies and Ferring pharmaceuticals. During his time at Ferring Graham was Global Head of Market Access and Pricing taking responsibility for all market access activities from incorporation of payer value into clinical development programs through to development and implementation of the market access and pricing strategy for global product launches of both pharmaceutical and diagnostic products.

Graham’s consultancy experience was obtained within both IMS consulting (previously Cambridge Pharma) and Adelphi Values whereby he was responsible for global pricing and reimbursement projects ranging from strategic insights to global pharmaceutical companies; market access training to senior management and affiliates; development of biosimilar access strategies and EU pricing and reimbursement submissions; landscape assessments for pharmaceutical and diagnostics within the EU and US
.
Graham has worked across many therapeutic areas including Gastroenterology, Urology, Fertility, Oncology, Obstetrics, Infectious Diseases and Endocrinology. Graham has a Ph.D. in neuropharmacology from Durham University and an MBA from Aston University.

Save This Event

Event Saved